Antiretroviral therapy was a dominant theme of the 12th Conference on Retroviruses and Opportunistic Infections. Key focus areas were new drug advances, management strategies for treatment-naive and treatment-experienced patients, the growing experience with antiretrovirals in the developing world, prevention of mother-to-child transmission of HIV, and the implications of HIV resistance. This review will highlight the major findings relevant to clinicians and clinical investigators.